​

Glaukos (GKOS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GKOS Stock Forecast

Glaukos (GKOS) stock forecast, based on 21 Wall Street analysts, predicts a 12-month average price target of $152.00, with a high of $185.00 and a low of $120.00. This represents a -4.41% decline from the last price of $159.01.

$50 $80 $110 $140 $170 $200 High: $185 Avg: $152 Low: $120 Last Closed Price: $159.01

GKOS Stock Rating

Glaukos stock's rating consensus is Buy, based on 21 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (76.19%), 4 Hold (19.05%), 1 Sell (4.76%), and 0 Strong Sell (0.00%).

Buy
Total 21 1 4 16 0 Strong Sell Sell Hold Buy Strong Buy

GKOS Forecast vs Benchmarks

TypeNameUpside
StockGlaukos-4.41%
SectorHealthcare Stocks 25.20%
IndustryMedical Device Stocks6.39%

Price Target Trends

1M3M12M
# Anlaysts1617
Avg Price Target$175.00$153.67$139.76
Last Closing Price$159.01$159.01$159.01
Upside/Downside10.06%-3.36%-12.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 253821-14
Dec, 243841-16
Nov, 24574--16
Oct, 24564--15
Sep, 24564--15
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 31, 2024Thomas StephanStifel Nicolaus$175.00$149.9416.71%10.06%
Dec 18, 2024Richard NewitterTruist Financial$185.00$145.1427.46%16.34%
Dec 02, 2024Thomas StephanStifel Nicolaus$153.00$140.189.15%-3.78%
Dec 02, 2024Patrick WoodMorgan Stanley$120.00$140.80-14.77%-24.53%
Nov 05, 2024David SaxonNeedham$149.00$127.4516.91%-6.30%
Nov 05, 2024Ryan ZimmermanBTIG$140.00$127.869.49%-11.96%
Oct 29, 2024Michael SarconeJefferies$155.00$134.0815.60%-2.52%
Oct 21, 2024Samuel BrodovskyTruist Financial$152.00$132.8714.40%-4.41%
Oct 17, 2024Matt O'BrienPiper Sandler$140.00$128.209.20%-11.96%
Sep 23, 2024Ryan ZimmermanBTIG$139.00$127.788.78%-12.58%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jan 03, 2025BTIGBuyBuyhold
Dec 11, 2024CitigroupBuyBuyupgrade
Dec 02, 2024Morgan StanleyEqual-WeightUnderweightdowngrade
Oct 29, 2024JefferiesBuyBuyhold
Oct 17, 2024Piper SandlerOverweightOverweighthold
Sep 23, 2024BTIGBuyBuyhold
Aug 28, 2024BTIGBuyBuyhold
Jul 15, 2024Morgan StanleyEqual-WeightEqual-Weighthold
May 22, 2024Wells FargoBuyBuyhold
May 22, 2024CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.70$-1.07$-2.09$-2.78-----
Avg Forecast$-1.50$-0.88$-2.20$-2.22$-1.82$-1.05$-0.25$0.42$1.18
High Forecast$-1.58$-0.92$-2.30$-2.26$-2.00$-1.32$-0.38$0.39$1.12
Low Forecast$-1.40$-0.82$-2.02$-2.16$-1.71$-0.75$0.08$0.44$1.24
Surprise %80.00%21.59%-5.00%25.23%-----

Revenue Forecast

$200M $360M $520M $680M $840M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$224.96M$294.01M$282.86M$314.71M-----
Avg Forecast$220.00M$288.16M$279.63M$313.00M$378.54M$479.13M$609.94M$745.10M$916.05M
High Forecast$208.57M$273.19M$261.89M$312.87M$377.81M$458.02M$609.12M$713.86M$877.64M
Low Forecast$228.57M$299.38M$289.59M$313.16M$378.96M$499.83M$610.76M$776.53M$954.70M
Surprise %2.25%2.03%1.16%0.55%-----

Net Income Forecast

$-200M $-140M $-80M $-20M $40M $100M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-120.35M$-49.59M$-99.19M$-134.66M-----
Avg Forecast$-139.09M$-60.89M$-56.35M$-134.66M$-89.64M$-50.13M$-7.30M$20.10M$57.15M
High Forecast$-166.91M$-75.99M$-73.50M$-174.21M$-96.64M$-64.01M$-18.60M$19.00M$54.04M
Low Forecast$-111.27M$-45.79M$-39.19M$-95.11M$-82.63M$-36.24M$4.00M$21.20M$60.29M
Surprise %-13.47%-18.55%76.04%------

GKOS Forecast FAQ

Is Glaukos stock a buy?

Glaukos stock has a consensus rating of Buy, based on 21 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 4 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Glaukos is a favorable investment for most analysts.

What is Glaukos's price target?

Glaukos's price target, set by 21 Wall Street analysts, averages $152 over the next 12 months. The price target range spans from $120 at the low end to $185 at the high end, suggesting a potential -4.41% change from the previous close price of $159.01.

How does Glaukos stock forecast compare to the average forecast of its sector, industry, and investment themes?

Glaukos stock forecast shows a -4.41% downside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the medical device stocks industry (6.39%).

What is the breakdown of analyst ratings for Glaukos over the past three months?

  • January 2025: 21.43% Strong Buy, 57.14% Buy, 14.29% Hold, 7.14% Sell, 0% Strong Sell.
  • December 2024: 18.75% Strong Buy, 50.00% Buy, 25.00% Hold, 6.25% Sell, 0% Strong Sell.
  • November 2024: 31.25% Strong Buy, 43.75% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Glaukos’s EPS forecast?

Glaukos's average annual EPS forecast for its fiscal year ending in December is -1.82 for 2024, a -34.53% decrease from the reported $-2.78 in 2023. The prediction for 2025 is $-1.05, $-0.25 for 2026, $0.42 for 2027, and $1.18 for 2028.

What is Glaukos’s revenue forecast?

Glaukos's average annual revenue forecast for its fiscal year ending in December is $378.54M for 2024, a 20.28% increase from the reported $314.71M in 2023. The forecast for 2025 is $479.13M, $609.94M for 2026, $745.1M for 2027, and $916.05M for 2028.

What is Glaukos’s net income forecast?

For its fiscal year ending in December, Glaukos's average annual net income forecast is $-89.637M for 2024, reflecting a -33.44% decrease from the reported $-135M in 2023. The projection for 2025 is $-50.125M, $-7.3M for 2026, $20.1M for 2027, and $57.15M for 2028.